These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16401719)

  • 41. Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes.
    Tamburini J; Elie C; Park S; Beyne-Rauzy O; Gardembas M; Berthou C; Mahe B; Sanhes L; Stamatoullas A; Vey N; Aouba A; Slama B; Quesnel B; Vekhoff A; Sotto JJ; Vassilief D; Al-Nawakil C; Fenaux P; Dreyfus F; Bouscary D;
    Leuk Res; 2009 Apr; 33(4):547-50. PubMed ID: 18640718
    [No Abstract]   [Full Text] [Related]  

  • 42. New strategy of antiangiogenic therapy for hepatocellular carcinoma.
    Wu XZ
    Neoplasma; 2008; 55(6):472-81. PubMed ID: 18999874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thalidomide and bowel perforation: four cases in one hospital.
    McClay H; Cervi P
    Br J Haematol; 2008 Feb; 140(3):360-1. PubMed ID: 18042266
    [No Abstract]   [Full Text] [Related]  

  • 44. Thalidomide for the nephrologist.
    Izzedine H; Launay-Vacher V; Deray G
    Nephrol Dial Transplant; 2005 Sep; 20(9):2011-2. PubMed ID: 16046513
    [No Abstract]   [Full Text] [Related]  

  • 45. Tumor lysis syndrome in a multiple myeloma treated with thalidomide.
    Fuente N; Mañe JM; Barcelo R; Muñoz A; Perez-Hoyos T; Lopez-Vivanco G
    Ann Oncol; 2004 Mar; 15(3):537. PubMed ID: 14998862
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
    Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M
    Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spontaneous tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma.
    Mehrzad R; Saito H; Krahn Z; Feinstein A
    Med Princ Pract; 2014; 23(6):574-6. PubMed ID: 24642955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.
    Ballanti S; Mastrodicasa E; Bolli N; Lotti F; Capolsini I; Berchicci L; Merigiola C; Giordano G; Tabilio A
    Nat Clin Pract Oncol; 2007 Dec; 4(12):722-5. PubMed ID: 18037876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pancoast syndrome caused by metastasis to the superior mediastinum of hepatocellular carcinoma.
    Hung JJ; Lin SC; Hsu WH
    Thorac Cardiovasc Surg; 2007 Oct; 55(7):463-5. PubMed ID: 17902073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Thalidomide-associated bradycardia in patients with hematologic diseases: a single institution experience].
    López-de la Cruz I; Aguayo-González A; López-Karpovitch X
    Rev Invest Clin; 2006; 58(5):424-31. PubMed ID: 17408102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases.
    Jang JW; Kay CS; You CR; Kim CW; Bae SH; Choi JY; Yoon SK; Han CW; Jung HS; Choi IB
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):412-8. PubMed ID: 18963538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thalidomide and venous thrombosis.
    Escudier B; Lassau N; Leborgne S; Angevin E; Laplanche A
    Ann Intern Med; 2002 May; 136(9):711. PubMed ID: 11992318
    [No Abstract]   [Full Text] [Related]  

  • 54. Thalidomide use and digital gangrene.
    Kang TY; Lowe CJ; Sekeres MA
    J Clin Oncol; 2006 Nov; 24(33):5328. PubMed ID: 17114666
    [No Abstract]   [Full Text] [Related]  

  • 55. Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma.
    Imam SZ; Zahid MF; Maqbool MA
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):168-170. PubMed ID: 29684339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
    Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
    Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localized dyskeratotic plaque with milia associated with sorafenib.
    Chappell JA; Burkemper NM; Semchyshyn N
    J Drugs Dermatol; 2009 Jun; 8(6):573-6. PubMed ID: 19537383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.
    Pang R; Poon RT
    Cancer Lett; 2006 Oct; 242(2):151-67. PubMed ID: 16564617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer.
    Buttin BM; Moore MJ
    Gynecol Oncol; 2008 Dec; 111(3):546-8. PubMed ID: 18191185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low dose of thalidomide can be effective in advanced hepatocellular carcinoma.
    Chen SC; Tsai HJ; Jan CM; Wang YH; Chen LT
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1868-9. PubMed ID: 17074035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.